Who is this course for?
This listing is marked as Professional course in Ketamine Therapy, MDMA Therapy, Psilocybin Therapy, Integration, Clinical & Medical, Research & Science. Check the provider page for final admission or eligibility details.
Integrating Psychedelics with Evidence-Based Therapy is a 12-week reading and study group for individuals interested in evidence-based therapy and its application in psychedelic therapy. The course is designed for clinicians, graduate students, researchers, or the public who have a background in the
Fluence
English
12 Weeks
Integrating Psychedelics with Evidence-Based Therapy is a 12-week reading and study group for individuals interested in evidence-based therapy and its application in psychedelic therapy. The course is designed for clinicians, graduate students, researchers, or the public who have a background in the scientific understanding of clinical interventions.
The course includes weekly discussion groups based on assigned readings that primarily come from academic literature. Topics will range from various evidenced-based therapies such as ACT, MI, CBT, and DBT to psychedelics like psilocybin, ketamine, and MDMA and their application in various clinical populations.
The course also critiques the current state of psychedelic therapy research and its ethical concerns. By the end of the course, participants will have a comprehensive understanding of the history, basic components, safety concerns, and pharmacology of psychedelic therapy, as well as the role of psychotherapy in psychedelic treatment.
This course runs multiple times per year.
Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.
This listing is marked as Professional course in Ketamine Therapy, MDMA Therapy, Psilocybin Therapy, Integration, Clinical & Medical, Research & Science. Check the provider page for final admission or eligibility details.
Format: Live Classes. Time commitment: 12 Weeks.
The listed price is $1,200. Confirm the latest tuition, fees, and payment options with [object Object].
Accreditation note: CE. Confirm credential eligibility directly with the provider before enrolling.
The current listing status is No New Dates. The course website was not reachable in the latest check, so use the provider or similar-course links as a backup.
By CIIS
Same course category
The Psychedelic-Assisted Therapies and Research Certificate Program at the California Institute for Integral Studies (CIIS) Center for Psychedelic Therapies and Research (CPTR) is designed to meet the growing need for the training of skilled therapists and researchers in the field of psychedelic-ass
Next cohort: Jun 1, 2026
Source lists: Estimated 145 hours
Delivery: San Francisco, United States + Online + Portland, United States
By SCPTR
Same course category
Salt City Psychedelic Therapy and Research (SCPTR) presents the Psychedelic Therapy Training Program, an all-encompassing 8-week course tailored for those who are keen to embark on a career as therapists and healers in the rapidly emerging domain of psychedelic therapy.
By Instituto Alma Viva
Same course category
Explore the first MEC-approved Postgraduate Course in Psychedelic-Assisted Psychotherapy in Brazil, designed for psychologists and psychiatrists. Learn cutting-edge therapeutic techniques, gain practical experience, and contribute to pioneering research.
Source lists: 360 hours
Delivery: Online + São Paulo, Brazil
No medicine self-experience listed